Monthly Archives: October 2016

An interview with Piotr Wysocki and Iwona Wawer on the European Joint Action’s work from a Polish-partner perspective

hareact_piotr_iwona

The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including tuberculosis (TB) and viral hepatitis among people who inject drugs (PWID). The project is primarily funded by the European Union and implemented by 23 partners in 18 member states. There are also 14 additional collaborating partners including the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Health

An interview with Heino Stöver on the European Joint Action’s work on infectious diseases in prisons

heino

The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including tuberculosis (TB) and viral hepatitis among people who inject drugs (PWID). The project is primarily funded by the European Union and implemented by 23 partners in 18 member states. There are also 14 additional collaborating partners including the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 

Health
1

An interview with Mika Salminen on the European Joint Action HA-REACT

mikasalminen

The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including tuberculosis (TB) and viral hepatitis among people who inject drugs (PWID). The project is primarily funded by the European Union and implemented by 23 partners in 18 member states. There are also 14 additional collaborating partners including the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Health